Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors.

de Koning HJ, van Ineveld BM, van Oortmarssen GJ, de Haes JC, Collette HJ, Hendriks JH, van der Maas PJ.

Int J Cancer. 1991 Oct 21;49(4):531-7.

PMID:
1917154
2.

Breast cancer screening; cost-effective in practice?

De Koning HJ.

Eur J Radiol. 2000 Jan;33(1):32-7.

PMID:
10674787
3.
4.

Cost effectiveness of the NHS breast screening programme: life table model.

Pharoah PD, Sewell B, Fitzsimmons D, Bennett HS, Pashayan N.

BMJ. 2013 May 9;346:f2618. doi: 10.1136/bmj.f2618. Erratum in: BMJ. 2013;346:f3822.

5.

Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.

Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de Koning HJ.

J Natl Cancer Inst. 2008 Sep 17;100(18):1290-300. doi: 10.1093/jnci/djn292.

PMID:
18780864
6.

A cost utility analysis of mammography screening in Australia.

Hall J, Gerard K, Salkeld G, Richardson J.

Soc Sci Med. 1992 May;34(9):993-1004.

PMID:
1631612
7.

Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany.

Warmerdam PG, de Koning HJ, Boer R, Beemsterboer PM, Dierks ML, Swart E, Robra BP.

J Epidemiol Community Health. 1997 Apr;51(2):180-6.

8.

Cost-effectiveness of mammographic screening in Australia.

Carter R, Glasziou P, van Oortmarssen G, de Koning H, Stevenson C, Salkeld G, Boer R.

Aust J Public Health. 1993 Mar;17(1):42-50.

PMID:
8357894
9.

How cost-effective is breast cancer screening in different EC countries?

van Ineveld BM, van Oortmarssen GJ, de Koning HJ, Boer R, van der Maas PJ.

Eur J Cancer. 1993;29A(12):1663-8.

PMID:
8398290
10.

The cost-effectiveness of breast cancer screening.

van der Maas PJ, de Koning HJ, van Ineveld BM, van Oortmarssen GJ, Habbema JD, Lubbe KT, Geerts AT, Collette HJ, Verbeek AL, Hendriks JH, et al.

Int J Cancer. 1989 Jun 15;43(6):1055-60.

PMID:
2499553
11.

Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study.

Boer R, de Koning H, Threlfall A, Warmerdam P, Street A, Friedman E, Woodman C.

BMJ. 1998 Aug 8;317(7155):376-9.

13.

Retrospective cost-effectiveness analysis of screening mammography.

Stout NK, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG.

J Natl Cancer Inst. 2006 Jun 7;98(11):774-82.

PMID:
16757702
14.

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.

Saadatmand S, Tilanus-Linthorst MM, Rutgers EJ, Hoogerbrugge N, Oosterwijk JC, Tollenaar RA, Hooning M, Loo CE, Obdeijn IM, Heijnsdijk EA, de Koning HJ.

J Natl Cancer Inst. 2013 Sep 4;105(17):1314-21. doi: 10.1093/jnci/djt203.

PMID:
23940285
15.

Cost-effectiveness of digital mammography breast cancer screening.

Tosteson AN, Stout NK, Fryback DG, Acharyya S, Herman BA, Hannah LG, Pisano ED; DMIST Investigators..

Ann Intern Med. 2008 Jan 1;148(1):1-10.

16.
17.

Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age.

Salzmann P, Kerlikowske K, Phillips K.

Ann Intern Med. 1997 Dec 1;127(11):955-65. Erratum in: Ann Intern Med 1998 May 15;128(10):878.

PMID:
9412300
18.

Cost effectiveness of mammography screening for Chinese women.

Wong IO, Kuntz KM, Cowling BJ, Lam CL, Leung GM.

Cancer. 2007 Aug 15;110(4):885-95. Erratum in: Cancer. 2010 Jan 15;116(2):540.

19.

The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand.

Szeto KL, Devlin NJ.

Health Policy. 1996 Nov;38(2):101-15. Review.

PMID:
10160378
20.

Economic considerations in breast cancer screening of older women.

Brown ML.

J Gerontol. 1992 Nov;47 Spec No:51-8. Review.

PMID:
1430883

Supplemental Content

Support Center